Cargando…

Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma

BACKGROUND: Neuroblastoma (NBL) is the most common extracranial solid tumor in childhood, and patients with high-risk neuroblastoma had a relatively poor prognosis despite multimodal treatment. To improve immunotherapy efficacy in neuroblastoma, systematic profiling of the immune landscape in neurob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yunhu, Zeng, Yu, Xia, Xiangping, Zhou, Jian-Guo, Cao, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477712/ https://www.ncbi.nlm.nih.gov/pubmed/34569303 http://dx.doi.org/10.1177/10732748211033751

Ejemplares similares

Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

Establishment and Validation of a Peroxisome-related Gene Signature for Prognostic Prediction and Immune Distinction in Hepatocellular Carcinoma
por: Miao, Dan, et al.
Publicado: (2022)

Development and validation of a 21-gene prognostic signature in neuroblastoma
por: Gupta, Mehul, et al.
Publicado: (2023)

Establishment and validation of a novel immune-related prognostic signature in malignant pleural mesothelioma
por: Zhang, Xiangxin, et al.
Publicado: (2022)

Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma
por: Ma, Yibo, et al.
Publicado: (2023)

Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia
por: Yang, You, et al.
Publicado: (2022)

A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation
por: Yang, Xiao, et al.
Publicado: (2021)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Identification and External Validation of a Transcription Factor-Related Prognostic Signature in Pediatric Neuroblastoma
por: Wang, Rujia, et al.
Publicado: (2021)

Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma
por: Xia, Xinxin, et al.
Publicado: (2021)

Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients
por: Zhang, Zide, et al.
Publicado: (2020)

Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
por: Tang, Linsong, et al.
Publicado: (2022)

Pyroptosis-Related Gene Signature Predicts the Prognosis and Immune Infiltration in Neuroblastoma
por: Li, Wanrong, et al.
Publicado: (2022)

Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer
por: Wang, Nan, et al.
Publicado: (2018)

A signature based on five immune-related genes to predict the survival and immune characteristics of neuroblastoma
por: Ma, KeXin, et al.
Publicado: (2022)

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer
por: Chen, Yu, et al.
Publicado: (2021)

Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma
por: Zheng, Lian, et al.
Publicado: (2021)

Prognostic Signature of Immune Genes and Immune-Related LncRNAs in Neuroblastoma: A Study Based on GEO and TARGET Datasets
por: Zhong, Xiaodan, et al.
Publicado: (2021)

Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma
por: Xu, Dafeng, et al.
Publicado: (2020)

Establishment and experimental validation of a novel cuproptosis-related gene signature for prognostic implication in cholangiocarcinoma
por: Chen, Jialu, et al.
Publicado: (2022)

Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma
por: Feng, Chenzhao, et al.
Publicado: (2022)

Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Construction and validation of an immunity-related prognostic signature for breast cancer
por: Zhu, Tao, et al.
Publicado: (2020)

Establishment and validation of an eight-gene metabolic–related prognostic signature model for lung adenocarcinoma
por: Ma, Weishuang, et al.
Publicado: (2021)

Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes
por: Wang, Zhihao, et al.
Publicado: (2021)

Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
por: Zhang, Yan, et al.
Publicado: (2021)

Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer
por: Liang, Leilei, et al.
Publicado: (2022)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

Establishment and validation of a nomogram to predict cancer-specific survival in pediatric neuroblastoma patients
por: Chen, Weiming, et al.
Publicado: (2023)

A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer
por: Wang, Jie, et al.
Publicado: (2022)

Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes
por: Hu, Zhengang, et al.
Publicado: (2021)

Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer
por: Liu, Chen-Qian, et al.
Publicado: (2022)

Combined analysis of RNA‐sequence and microarray data reveals effective metabolism‐based prognostic signature for neuroblastoma
por: Meng, Xinyao, et al.
Publicado: (2020)

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
por: Su, Rongjia, et al.
Publicado: (2022)

Development and validation of an immune gene-set based Prognostic signature in ovarian cancer
por: Shen, Sipeng, et al.
Publicado: (2018)

A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation
por: Gong, Mingkai, et al.
Publicado: (2022)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma
por: Zeng, Liang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_if2k4v1rh84sscsojt1u5u6aou